DK0553294T3 - Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme - Google Patents

Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme

Info

Publication number
DK0553294T3
DK0553294T3 DK92900114T DK92900114T DK0553294T3 DK 0553294 T3 DK0553294 T3 DK 0553294T3 DK 92900114 T DK92900114 T DK 92900114T DK 92900114 T DK92900114 T DK 92900114T DK 0553294 T3 DK0553294 T3 DK 0553294T3
Authority
DK
Denmark
Prior art keywords
treatment
cell proliferation
compositions
preparation
proliferation disorders
Prior art date
Application number
DK92900114T
Other languages
Danish (da)
English (en)
Inventor
Lawrence M Blatt
Milton W Taylor
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0553294T3 publication Critical patent/DK0553294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92900114T 1990-10-17 1991-10-15 Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme DK0553294T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15
PCT/US1991/007722 WO1992006707A1 (en) 1990-10-17 1991-10-15 Methods and compositions for the treatment of cell proliferation disorders

Publications (1)

Publication Number Publication Date
DK0553294T3 true DK0553294T3 (da) 1999-08-23

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900114T DK0553294T3 (da) 1990-10-17 1991-10-15 Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme

Country Status (17)

Country Link
EP (1) EP0553294B1 (zh)
JP (1) JP3496937B2 (zh)
CN (1) CN1053117C (zh)
AT (1) ATE174798T1 (zh)
AU (1) AU660633B2 (zh)
CA (1) CA2094275C (zh)
DE (1) DE69130679T2 (zh)
DK (1) DK0553294T3 (zh)
ES (1) ES2128348T3 (zh)
HK (1) HK1010340A1 (zh)
IE (1) IE913656A1 (zh)
IL (1) IL99778A (zh)
NO (1) NO931413L (zh)
NZ (1) NZ240264A (zh)
PT (1) PT99265B (zh)
SG (1) SG52537A1 (zh)
WO (1) WO1992006707A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
AU1299295A (en) * 1993-12-02 1995-06-19 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
WO2005113592A2 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
JP5209462B2 (ja) * 2005-03-09 2013-06-12 ウェイ グアンウェン コンセンサスインターフェロンの使用方法
WO2007044083A2 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
ATE174798T1 (de) 1999-01-15
CN1053117C (zh) 2000-06-07
NO931413D0 (no) 1993-04-16
SG52537A1 (en) 1998-09-28
EP0553294A4 (en) 1994-11-23
CA2094275C (en) 2003-06-03
WO1992006707A1 (en) 1992-04-30
DE69130679T2 (de) 1999-05-06
IE913656A1 (en) 1992-04-22
PT99265B (pt) 1999-04-30
HK1010340A1 (en) 1999-06-17
AU660633B2 (en) 1995-07-06
NO931413L (no) 1993-04-16
JP3496937B2 (ja) 2004-02-16
EP0553294A1 (en) 1993-08-04
CN1064018A (zh) 1992-09-02
DE69130679D1 (de) 1999-02-04
JPH06502426A (ja) 1994-03-17
IL99778A (en) 1996-11-14
PT99265A (pt) 1992-08-31
AU9023591A (en) 1992-05-20
EP0553294B1 (en) 1998-12-23
CA2094275A1 (en) 1992-04-18
NZ240264A (en) 1997-07-27
ES2128348T3 (es) 1999-05-16
IL99778A0 (en) 1993-02-21

Similar Documents

Publication Publication Date Title
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
IT1302559B1 (it) Busto ortopedico modulare regolabile per il trattamento dellascoliosi
DK288590D0 (da) Blandings/oploesnings-sproejte til cytostatika for medicinsk behandling af cancer patienter
DK108888D0 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
FR2657259B1 (zh)
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
DK162923C (da) Farmaceutisk praeparat til inhibering af tumorcellevaekst og fremgangsmaade til fremstilling deraf
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
DE69103824D1 (de) Patientenliegetische.
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
IT9019882A1 (it) Composizioni farmaceutiche comprendenti derivati del glicerolo-5- fosfato atte al trattamento di patologie del sistema nervoso
IT9067821A0 (it) Piastra complementare del tavolo chirurgico